期刊文献+

子宫内膜异位症与卵巢癌相关性临床分析 被引量:18

Association of endometriosis and ovarian cancer
下载PDF
导出
摘要 目的:探讨子宫内膜异位症(内异症)与卵巢癌的相关性。方法:收集199例卵巢癌患者,分内异症组(n=32),非内异症组(n=167),回顾性分析两组患者一般情况、临床表现、病理特征、实验室检查及预后。结果:内异症组平均年龄明显小于非内异症组(P<0.05),年龄<50岁、未生育患者构成比明显高于非内异症组;内异症组患者临床症状以月经改变和下腹痛、腹胀为主(P<0.05);内异症组肿瘤直径通常小于20cm,且主要在10-20cm之间,非内异症组肿瘤直径大部分为10-20cm;内异症组患者血CA125主要在200-1000k U/L之间,非内异症组大部分在200k U/L以下;内异症组患者以透明细胞癌、宫内膜样癌为主,非内异症组以浆液性囊腺癌为主(P<0.05);内异症组患者分期较早,I期、Ⅱ期占合并卵巢癌患者68.8%,非内异症组分期多处于Ⅱ期、Ⅲ期,占原发卵巢癌患者70.1%(P<0.05);内异症组患者病灶部位多位于左侧卵巢,非内异症组病灶部位在左侧、右侧、双侧分布较接近(P<0.05);内异症组5年生存率为59.4%,非内异症组5年生存率为34.7%,两组差异具有统计学意义(P<0.05)。结论:应充分了解内异症恶变的临床症状及病理特征,提高早期诊断率。 Objective :To investigate the association of endometriosis and ovarian cancer. Methods:All 198 cases with ovarian cancer were divided into endometriosis group (n = 32 ), non endometriosis group( n = 167 ), patients' general character, clinical manifestations, pathology, laboratory examination and prognosis were analysised. Results: The average age of endometriosis group was obviously less than that of non endometriosis group ( P 〈 0. 05 ) , age 〈 50 years old and unmarried patients in endometriosis group were more than that in non endometriosis group;clinical symptom were mostly abdominal pain, abdominal distension and menstrual (P 〈 0.05 ). Tumor diameter were usually less than 20cm, that in non endometriosis group were 10 -20cm. CA125 were mainly in range of 200 -1000kU/L, That in non endometriosis group were mostly below 200kU/L. Tumour types were mostly clear cell carcinoma, endometrioid carcinoma, that in non endometriosis group were mainly serous cystadenocarcinoma;tumor staging were mostly stage Ⅰ, stage Ⅱ accounted for 68.8% ,that in non endometriosis group were mostly stage Ⅱ, Ⅲ accounted for 70.1% (P〈0.05) ;lesions located mostly in left ovary, that in non endometriosis group were mostly close in left, right, bilateral distribution (P 〈0.05);5 year survival rate was 59.4%, that in non endometriosis group was 34.7% (P 〈 0.05 ). Conclusion: Clinicians should give priority to prevention, fully understand clinical symptoms and pathological characteristics of malignant transformation of endometriosis,to improve early diagnosis rate.
作者 宋建平
出处 《现代肿瘤医学》 CAS 2015年第10期1432-1434,共3页 Journal of Modern Oncology
关键词 子宫内膜异位症 卵巢癌 透明细胞癌 宫内膜样癌 endometriosis ovarian carcinoma clear cell carcinoma endometrioid carcinoma
  • 相关文献

参考文献12

  • 1Yumi H, Hirotaka K, HirQshi S, et al. Identification of multiplepathways involved in the malignant transformation of endometriosis[J]. Oncol Lett,2012,4( 1):3 -9.
  • 2Qingsong M, Weixue S, John J, et al. Identification of commonmechanisms between endometriosis and ovarian cancer [ J ]. J As-sist Reprod Genet,2011,28(10) :917 -923.
  • 3卢媛,刘茂华,郑峪,郭孙伟,刘惜时.卵巢上皮性癌合并卵巢子宫内膜异位症67例临床病理分析[J].中华妇产科杂志,2009,44(11):832-836. 被引量:5
  • 4付晨薇,郎景和,沈铿,黄慧芳,潘凌亚,吴鸣,杨佳欣.子宫内膜异位症合并卵巢恶性肿瘤的临床特点[J].协和医学杂志,2012,3(2):204-207. 被引量:5
  • 5Gram M,Zervoudis S,Evangelinakis N,et al. Endometrium and 0-varian cancer synchronous to endometriosis - A retrospective studyof our experience of 7 years[ J]. J Med Life,2010,3(1) :76 -79.
  • 6Aziz Aris. Endometriosis - associated ovarian cancer: A ten - yearcohort study of women living in the Estrie Region of Quebec[ J].Canada J Ovarian Res,2010,3 :2 -6.
  • 7Nezhat F,Datta MS,Hanson V,et al. The relationship of endom-etrinsis and ovarian maligTumcy : a review [ J ]. Fertil Steril, 2008,9:1559 -1570.
  • 8Tadashi T. Endometrioid adenocarcinoma of the ovary arising in a-typical endometriosis[ J]. Int J Clin Exp Pathol,2012,5 (9) :924-927.
  • 9Shannon M,Purvak P,Carolyn M. et al. Malignant transformation ofendometriosis within the urinary bladder[ J]. Proc ( Bayl Univ MedCent) ,2012,25(3) :293 -295.
  • 10任凤岩,张淑兰,姜彦多,王丹波.卵巢子宫内膜样癌及其合并子宫内膜异位症的临床及病理分析[J].中国实用妇科与产科杂志,2007,23(9):708-709. 被引量:18

二级参考文献67

  • 1任凤岩,李一宁.子宫内膜异位症的恶变问题[J].中国全科医学,2006,9(22):1848-1850. 被引量:9
  • 2徐冰,李卫平,狄文.子宫内膜异位症恶变研究进展[J].中国妇幼保健,2007,22(17):2434-2436. 被引量:5
  • 3王丹青,尹如铁,朱惠莉,徐炼.卵巢子宫内膜异位症恶变21例临床病理分析[J].华西医学,2007,22(3):518-519. 被引量:3
  • 4Modesitt SC, Tortolero - Luna G, Robinson JB, et al. Ovarian and extraovarian endometriosis - associated cancer [ J ]. Obstet Gynecol, 2002, 100(4) : 788-795.
  • 5Baiocchi G, Kavanagh JJ, Wharton JT. Endometrioid stromal sarcomas arising from ovarian and extraovarian endometriosis: report of two cases and review of the literature[J]. Gynecol Oncol, 1990,36( 1 ) 147-151.
  • 6Modugno F, Ness RB, Allen GO, et al. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis[ J]. Am J Obstet Gynecol, 2004,191 (3) :733-740.
  • 7Bese T, Simsek Y, Bese N, et al. Extensive pelvic endometriosis with malignant change in tamoxifen-treated postmenopausal women[J]. Int J Gynecol Cancer, 2003,13:376-380.
  • 8Cottreau CM, Ness RB, Modugno F, et al. Endometriosis and its treatment with Danazol or Lupron in relation to ovarian cancer [J]. Clinical Cancer Research, 2003, 9(14) : 5142-5144.
  • 9Erzen M, Rakar S, Klancnik B, et al. Endometriosis - associated ovarian carcinoma (EAOC) : an entity distinct from other ovarian carcinomas as suggested by a nested case - control study [J]. Gynecol Oncol,2001,83( 1 ) : 100-108.
  • 10Komiyama S, Aoki D, Tominaga E, et al. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis : clinicopathologic evaluation [ J ]. Gynecol Oncol, 1999,72 (3) :342-346.

共引文献41

同被引文献126

  • 1张晓霞,费军伟,于晓伟,倪劲松,王芯蕊,李荷莲.卵巢癌组织中PI3K的表达及意义[J].吉林大学学报(医学版),2008,34(6):1027-1030. 被引量:5
  • 2王宁宁,刘斌,谭金凤,丁慧娟,洪珊珊,郑清泉,柯佩琪,黄建昭,王子莲,周灿权.广东地区子宫内膜异位症的流行趋势与特点[J].中华临床医师杂志(电子版),2010,4(7):962-965. 被引量:17
  • 3叶霞,王丽宏,郭志杰.PTEN及P16蛋白表达变化对卵巢子宫内膜异位症癌变的影响[J].中国临床实用医学,2014(5):46-47. 被引量:2
  • 4林津,马炎辉,刘鹏博(编校).卵巢子宫内膜异位症相关因素分析[J].中国妇幼保健,2007,22(5):570-572. 被引量:9
  • 5Machado Linde F, Sdnchez-Ferrer ML, Cascales P, et al. Prevalence of endometriosis in epithelial ovarian cancer analysis of the associated clinical features and study on molecular mechanisms involved in the possible causality E J 1. Eur J Gynaecol 0ncol,2015,36(1) 21 24.
  • 6Samartzis EP,Noske A,Dedes KJ,et al.ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosisassociated ovarian carcinomas[J].Int J Mol Sci,2013,14(9):18824-18849.
  • 7Matsumoto T,Yamazaki M,Takahashi H,et al.Distinctβ-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas[J].Am J Clin Pathol,2015,144(3):452-463.
  • 8Wu RC,Ayhan A,Maeda D,et al.Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy[J].J Pathol,2014,232(4):473-481.
  • 9Yamamoto S,Tsuda H,Takano M,et al.PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma[J].J Pathol,2011,225(2):189-194.
  • 10Shigetomi H,Tsunemi T,Haruta S,et al.Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalities[J].Cancer Invest,2012,30(6):473-480.

引证文献18

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部